Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2004 Apr;20(4):188-91.
doi: 10.1016/S1607-551X(09)70105-6.

Development of hyperthyroidism following primary hypothyroidism: a case report

Affiliations
Case Reports

Development of hyperthyroidism following primary hypothyroidism: a case report

Yueh-Hua Chung et al. Kaohsiung J Med Sci. 2004 Apr.

Abstract

Development of hyperthyroidism following primary hypothyroidism is uncommon, and only a few documented cases have been reported. Alterations in thyroid-stimulating hormone receptor antibodies in serum are currently considered to play the main role in the pathophysiology, but the exact mechanism is still unknown. Here, we report the case of a 60-year-old man with disturbed consciousness due to hyponatremia. Thyroid function tests showed primary hypothyroidism with a high anti-microsomal antibody titer (1:6,400). The patient experienced weight loss and exophthalmos 6 years later. Serum thyroid hormone levels were increased and thyroxine treatment was discontinued, but the patient remained thyrotoxic 2 months later. 131I thyroid uptake was 40.9% at 24 hours, and bilateral thyroid lobes were not enlarged with diffuse radioactivity. Six months later, the patient was still thyrotoxic and therapy with methimazole 10 mg/day was started. He is now taking methimazole and is euthyroid.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Irvine WJ, Gray RS, Toft AD, et al. Spectrum of thyroid function in patients remaining in remission after antithyroid drug therapy for thyrotoxicosis. Lancet. 1977; ii: 179–181. - PubMed
    1. Kasagi K, Iida Y, Konishi J, et al. Paired determination of thyroid‐stimulating and TSH‐binding inhibitory activities in patients with Graves' disease during antithyroid drug treatment. Acta Endocrinol. 1986; 111: 474–480. - PubMed
    1. Bell PM, Sinnamon DG, Smyth PP, et al. Hyperthyroidism following primary hypothyroidism in association with polyendocrine autoimmunity. Acta Endocrinol. 1985; 108: 491–497. - PubMed
    1. Kasagi K, Konishi J, Iida Y, et al. Changes in thyroid stimulating and TSH‐binding inhibitory activities in a patient who developed hyperthyroidism due to Graves' disease following primary hypothyroidism. Clin Endocrinol. 1986; 25: 519–525. - PubMed
    1. Takeda K, Takamatsu J, Kasagi K, et al. Development of hyperthyroidism following primary hypothyroidism: a case report with changes in thyroid‐related antibodies. Clin Endocrinol. 1988; 28: 341–344. - PubMed

Publication types